Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Hong Kong Pharma Digital Technology Holdings Ltd. ( (HKPD) ).
On January 12, 2026, Cellyan Biotechnology Co., Ltd received a notice from Nasdaq that the closing bid price of its Class A ordinary shares had remained below US$1.00 for 30 consecutive business days between November 26, 2025 and January 9, 2026, putting the company out of compliance with Nasdaq’s minimum bid price requirement. The notification, disclosed in a January 16, 2026 filing and press release, does not immediately affect the stock’s listing status, and the shares continue to trade on the Nasdaq Capital Market under the ticker “HKPD.” Cellyan has 180 calendar days, until July 13, 2026, to regain compliance by lifting its share price to at least US$1.00 for ten consecutive business days, with a potential second 180-day grace period available if it meets other listing standards and commits to a remediation plan, which could include a reverse share split. The notice underscores mounting pressure on the company’s market valuation and could have ramifications for investor sentiment and liquidity if compliance is not restored within the prescribed timelines, although the company is currently evaluating options to resolve the deficiency.
More about Hong Kong Pharma Digital Technology Holdings Ltd.
Cellyan Biotechnology Co., Ltd, formerly Hong Kong Pharma Digital Technology Holdings Limited, is a Hong Kong-based provider of over-the-counter (OTC) pharmaceutical cross-border e-commerce supply chain services and OTC pharmaceutical procurement and distribution. Through subsidiaries Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, it connects OTC suppliers, logistics firms and merchants on Chinese e-commerce platforms to offer Mainland Chinese customers a one-stop solution for overseas OTC medicines, covering product sourcing, regulatory enlistment, permitting, storage, packaging and end-to-end delivery.
Average Trading Volume: 147,966
Technical Sentiment Signal: Strong Sell
Current Market Cap: $8.77M
See more data about HKPD stock on TipRanks’ Stock Analysis page.